Join the Oncology Voice Network. Join for Free
HOLD MY BEER… I’m Going to be an MSL
Medical Science Liaison career transition mentorship networking transferable skills

HOLD MY BEER… I’m Going to be an MSL


Share This Article


Summary

In this episode, Lana Lucidi shares her journey from early career roles to becoming a Medical Science Liaison. She delves into her transition process, highlighting the importance of mentorship, networking, and leveraging transferable skills. Lana addresses common challenges faced when pursuing an MSL role, particularly navigating job descriptions and targeting the right companies. She offers valuable advice for aspiring MSLs, emphasizing the significance of building expertise and confidence, especially when engaging with Key Opinion Leaders (KOLs). The episode concludes with reflections on the MSL role, the impact of the MSL Talk podcast, and words of encouragement for those on the MSL path.

My guest this week is Lana Luccitti, Medical Science Liaison with Topcon Health who discusses how it is possible to land an MSL role without a Doctorate.

Lana shares…

👉 What made her want to be an MSL
👉 The first thing she did in her MSL Search
👉 The frustrations she had along the way
👉 What helped her stand out from others
👉 Most important advice she can offer

Click for Source
Medical Science Liaison, career transition, mentorship, networking, transferable skills

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Surround to Succeed: Building a Motivational Network
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

Surround to Succeed: Building a Motivational Network

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN